Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review

Fig. 1

Comparison of HBV-DNA positive results on 103 non-discriminating reactive and 39 HBV NAT-yield samples in the Ultrio Elite ID-NAT (□) and MPX2.0 ID-NAT (■). Non-discriminating reactive indicates 103 screening tests positive but non-discriminating reactive samples, HBV NAT-yield indicates 39 HBV NAT+ELISA yield OBI samples, and overall refers to all 142 specimens

Back to article page